Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-02 7:10 pm Purchase | 2025-12-22 | 13D | IN8bio, Inc. INAB | FAIRBAIRN EMILY | 733,293 7.500% | 733,293 (New Position) | Filing History |
| 2025-12-30 1:56 pm Purchase | 2025-12-22 | 13G | IN8bio, Inc. INAB | 683 Capital Management, LLC | 770,445 7.860% | 770,445 (New Position) | Filing History |
| 2025-12-29 4:00 pm Purchase | 2025-12-22 | 13D | IN8bio, Inc. INAB | BIOS Fund II, LP | 391,357 4.000% | 87,355 (+28.73%) | Filing History |
| 2025-12-22 5:15 pm Purchase | 2025-12-19 | 13G | IN8bio, Inc. INAB | Stonepine Capital Management, LLC | 1,007,990 9.900% | 1,007,990 (New Position) | Filing History |
| 2025-08-14 5:50 pm Sale | 2025-06-30 | 13G | IN8bio, Inc. INAB | Alyeska Investment Group, L.P. | 89,021 2.580% | -152,348 (-63.12%) | Filing History |
| 2025-08-13 4:55 pm Purchase | 2025-06-30 | 13G | IN8bio, Inc. INAB | Transcend Partners Opportunity Fund LLC | 107,416 2.600% | 107,416 (New Position) | Filing History |
| 2025-08-13 4:53 pm Purchase | 2025-06-30 | 13G | IN8bio, Inc. INAB | Ho William Tai-Wei | 151,223 3.700% | 151,223 (New Position) | Filing History |
| 2025-07-29 4:05 pm Sale | 2025-06-30 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 149,895 4.400% | -56,501 (-27.37%) | Filing History |
| 2025-05-08 5:53 pm Sale | 2025-05-02 | 13D | IN8bio, Inc. INAB | BIOS Fund II, LP | 304,002 9.990% | -43,203 (-12.44%) | Filing History |
| 2025-02-14 4:41 pm Purchase | 2024-12-31 | 13G | IN8bio, Inc. INAB | Ho William Tai-Wei | 136,627 5.600% | 32,410 (+31.10%) | Filing History |
| 2025-02-14 4:29 pm Purchase | 2024-12-31 | 13G | IN8bio, Inc. INAB | Alyeska Investment Group, L.P. | 241,369 9.900% | 241,369 (New Position) | Filing History |
| 2025-01-31 4:05 pm Sale | 2024-12-31 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 206,396 8.500% | -18,202 (-8.10%) | Filing History |
| 2024-10-11 6:01 pm Unchanged | 2024-10-04 | 13D | IN8bio, Inc. INAB | BIOS Fund II, LP | 347,206 23.100% | 0 (Unchanged) | Filing History |
| 2024-10-09 5:19 pm Purchase | 2024-10-01 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 224,598 9.300% | 146,775 (+188.60%) | Filing History |
| 2024-09-17 7:30 pm Sale | 2024-06-14 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 77,822 4.990% | -58,790 (-43.03%) | Filing History |
| 2024-02-13 4:04 pm Purchase | 2023-12-31 | 13G | IN8bio, Inc. INAB | Ho William Tai-Wei | 104,217 7.100% | 7,520 (+7.78%) | Filing History |
| 2023-12-15 4:31 pm Sale | 2023-12-13 | 13G | IN8bio, Inc. INAB | Transcend Partners Opportunity Fund LLC | 107,416 7.500% | -29,649 (-21.63%) | Filing History |
| 2023-12-15 06:26 am Purchase | 2023-12-11 | 13G | IN8bio, Inc. INAB | Orin Hirschman | 136,612 9.400% | 136,612 (New Position) | Filing History |
| 2023-12-15 06:08 am Purchase | 2023-12-13 | 13D | IN8bio, Inc. INAB | BIOS Fund II, LP | 347,206 23.100% | 125,943 (+56.92%) | Filing History |
| 2023-08-11 4:28 pm Purchase | 2021-12-31 | 13G | IN8bio, Inc. INAB | Ho William Tai-Wei | 96,697 9.100% | 96,697 (New Position) | Filing History |